XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Shares          
Granted (in shares)     0    
Weighted- Average Exercise Price          
Granted (in dollars per share)     $ 0    
2018 Omnibus Incentive Plan          
Shares          
Outstanding, beginning of period (in shares)     694,519    
Granted (in shares) 0 0 0 0  
Exercised (in shares)     (41,725)    
Forfeited or expired (in shares)     (8,460)    
Outstanding, end of period (in shares) 644,334   644,334   694,519
Vested or expected to vest, end of period (in shares) 644,334   644,334    
Exercisable, end of period (in shares) 397,553   397,553    
Weighted- Average Exercise Price          
Outstanding, beginning of period (in dollars per share)     $ 7.79    
Exercised (in dollars per share)     7.46    
Forfeited or expired (in dollars per share)     9.92    
Outstanding, end of period (in dollars per share) $ 7.79   7.79   $ 7.79
Vested or expected to vest, end of period (in dollars per share) 7.79   7.79    
Exercisable, end of period (in dollars per share) $ 6.77   $ 6.77    
Additional Disclosures          
Weighted average remaining contractual term, outstanding, beginning of period     3 years 2 months 12 days   4 years
Weighted average remaining contractual term, outstanding, beginning of period     3 years 2 months 12 days   4 years
Weighted average remaining contractual term, vested or expected to vest, end of period     3 years 2 months 12 days    
Weighted average remaining contractual term, exercisable, end of period     2 years 2 months 12 days    
Aggregate intrinsic value, outstanding, beginning of period (in dollars)     $ 29,744    
Aggregate intrinsic value, outstanding, end of period (in dollars) $ 20,589   20,589   $ 29,744
Aggregate intrinsic value, vested or expected to vest, end of period (in dollars) 20,589   20,589    
Aggregate intrinsic value, exercisable, end of period (in dollars) $ 13,108   $ 13,108